Endothelial progenitor cells: Cellular biomarkers in vascular disease

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 3-4, 2008, Pages

  Hristov, Mihail ^a   Weber, Christian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE; BEVACIZUMAB; CYTOKINE; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2 ANTAGONIST;

ARTERY INJURY; ATHEROSCLEROSIS; CELL COUNT; CELL FUNCTION; CELL REGENERATION; CELL THERAPY; CLINICAL TRIAL; COLONY FORMING UNIT; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG RESPONSE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; STEM CELL; VALIDATION PROCESS; VASCULAR DISEASE;

EID: 67649395914     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.07.001     Document Type: Review

References (40)

1. Libby P., and Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8 (2002) 1257-1262
2. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6 (2006) 508-519
3. Hristov M., and Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell Mol. Med. 8 (2004) 498-508
4. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
5. Peichev M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
6. Bertolini F., et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer 6 (2006) 835-845
7. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
8. Yamashita J., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 (2000) 92-96
9. Yoon Y.S., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115 (2005) 326-338
10. Zengin E., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133 (2006) 1543-1551
11. Harraz M., et al. CD34-blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
12. Zhao Y., et al. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2426-2431
13. Deschaseaux F., et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur. J. Pharmacol. 562 (2007) 111-118
14. Redondo S., et al. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3-lymphocyte sub-population. J. Immunol. Methods 335 (2008) 21-27
15. De Palma M., et al. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28 (2007) 519-524
16. Elsheikh E., et al. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood 106 (2005) 2347-2355
17. Hristov M., et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100 (2007) 590-597
18. Walter D.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
19. Werner N., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93 (2003) e17-24
20. Rauscher F.M., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003) 457-463
21. Hu Y., et al. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108 (2003) 3122-3127
22. Hristov M., et al. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J. Cell Mol. Med. 10 (2006) 727-733
23. Gruh I., et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113 (2006) 1326-1334
24. Werner N., and Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 257-266
25. Guven H., et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J. Am. Coll Cardiol. 48 (2006) 1579-1587
26. Xiao Q., et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis - results from a large population-based study. PLoS ONE 2 (2007) e975
27. Hristov M., et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192 (2007) 413-420
28. Leone A.M., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur. Heart J. 26 (2005) 1196-1204
29. Madjid M., et al. Leukocyte count and coronary heart disease: implications for risk assessment. J. Am. Coll Cardiol. 44 (2004) 1945-1956
30. George J., et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2636-2641
31. Purhonen S., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 6620-6625
32. Braunstein M., et al. Endothelial progenitor cells display clonal restriction in multiple myeloma. BMC Cancer 6 (2006) 161
33. Weber C., et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67 (2000) 699-704
34. Sandri M., et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111 (2005) 3391-3399
35. Pistrosch F., et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183 (2005) 163-167
36. Wang C.H., et al. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J. Mol. Cell Cardiol. 41 (2006) 34-43
37. Duda D.G., et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat. Protoc. 2 (2007) 805-810
38. Van Craenenbroeck E.M., et al. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J. Immunol. Methods 332 (2008) 31-40
39. Schober A., et al. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. Am. J. Cardiol. 96 (2005) 1116-1122
40. George J., et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J. 25 (2004) 1003-1008